Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 25. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1446ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineH322MNANAXTT assayLog10 pfu/cell70% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1458ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.069 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1464ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.092NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1470ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.133NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1476ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.078 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1482ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.081NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1488ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (>100 micromolar, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.084NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1494ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1500ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1506ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1512ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1518ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1524ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (>100, ratio is 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1530ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1536ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1542ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1548ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1554ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1560ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1566ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1572ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1578ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:20)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1584ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1590ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1596ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(>100, 1:200)NoNCIHuman NSCLC cell lineH322MNANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI >10NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950